Aller au contenu principal
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Rechercher
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIOuvrir ce point de menu principal
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsOuvrir ce point de menu principal
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
  • Facilities and InstrumentsOuvrir ce point de menu principal
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesOuvrir ce point de menu principal
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsOuvrir ce point de menu principal
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

Vous êtes ici:

  1. PSI Home
  2. Labs & User Services
  3. BIO
  4. Center for Radiopharmaceutical Sciences (CRS)

Navigation secondaire

Center for Radiopharmaceutical Sciences (CRS)

  • Laboratory Head
  • Project Leader
  • Scientific Highlights
  • Groups
    • Nuclide Chemistry
    • Pharmacology
    • Clinical Drug Supply
    • Radionuclide-Production and Maintenance
    • Radionuclide Development
  • Facilities and Instruments
  • Teaching and Education
  • Publications
  • Team / Contact
  • News & Events

Info message

Ce contenu n'est pas disponible en français.

Center for Radiopharmaceutical Sciences (CRS)

The Center for Radiopharmaceutical Sciences (CRS), headed by Prof. Dr. Roger Schibli, is a joint endeavor between the Paul Scherrer Institute and the ETH Zurich. CRS is working towards clinical application of radiopharmaceuticals based on an interdisciplinary approach involving radiochemistry, radiopharmaceutical chemistry, biochemistry, molecular biology, pharmacy and pharmacology.

CRS offer the entire spectrum of radiopharmaceutical sciences which includes radionuclide devlopment (in close cooperation with the Laboratory of Radiochemistry at PSI), radiolabeling chemistry, lead-optimization, in vitro and in vivo assessment, pre-clinical nuclear imaging (PET and SPECT) and radionuclide therapy as well as translation of new and novel radiotracers for clinical studies (in collaboration with academic and industrial partners).

Hiking day one

Sidebar

Contact

Prof. Dr. Roger Schibli
Center for Radiopharmaceutical Sciences
Paul Scherrer Institut
OIPA/103
5232 Villigen PSI
Switzerland

Telephone Office: +41 56 310 28 43
E-mail Office: sandha.keller@psi.ch

Contact

ETH
Prof. Dr. Roger Schibli
Swiss Federal Institute of Technology Zurich
Radiopharmaceutical Sciences
ETH Zurich

Contact

University Hospital Zurich
Radiopharmacy
USZ

Itinéraire PSI

Comment nous trouver (l'itinéraire et plan d'accès)
top

Pied de page

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Suisse

Téléphone: +41 56 310 21 11
Téléfax: +41 56 310 21 99

Comment nous trouver 
Contact

Centre de visiteurs psi forum
Laboratoire élèves iLab (en allemand)
Centre de protonthérapie
Centre de Formation du PSI
PSI Guest House (en anglais)
PSI Gastronomie (en allemand)
psi forum shop

Service & Support

  • Annuaire
  • User Office
  • Accelerator Status
  • Publications du PSI
  • Fournisseurs
  • E-facture
  • Computing (en anglais)
  • Sicherheit (en allemand)

Carrière

  • Travailler au PSI
  • Offres d'emploi
  • Formation initiale et formation continue
  • Career Center
  • Formation professionnelle (en allemand)
  • Centre de Formation du PSI

Pour les médias

  • Le PSI en bref
  • Chiffres et faits
  • Le coin médias
  • Communiqués de presse
  • Réseaux sociaux

Suivez le PSI: Twitter (in English) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Impressum
  • Conditions d'utilisation
  • Login éditeurs